X

Natural Capsules Ltd Stock Analysis

Small Cap
Evaluated by 289 users | BSE: 524654 | NSE: |
Pharmaceuticals & Drugs
Natural Capsules is a public limited company established in the year 1993.The company is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.   The company meets...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 15.6%15.08%16.25%10.78%12.04%8.13%2.6%2.24%3.72%1.84%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 34.143.853.558.567.362.153.654.859.861.6
Y-o-Y Gr. Rt.-28.2%22.2%9.5%15%-7.8%-13.6%2.1%9.2%3%
Adjusted EPS (Rs.) 9.9510.8213.78.4810.497.081.641.632.840.79
Y-o-Y Gr. Rt.-8.7%26.6%-38.1%23.7%-32.5%-76.8%-0.6%74.2%-72.2%
Book Value per Share (Rs.) 59.8169.3381.6484.2689.3592.4186.5887.1689.0489.24
Adjusted Net Profit 4.54.96.24.35.54.1111.80.5
Net Op. Cash Flow (Rs. Cr.) 5.66.47.375.43.51.95.42.17.2
Debt to Cash Flow from Ops 1.611.581.380.8711.61.5502.580.87
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Natural Capsules Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 6.8%-1.8%4.7%3%
Adjusted EPS -24.5%-40.4%-21.6%-72.2%
Book Value per Share 4.6010.2
Share Price 14.4% 6% 9.1% 194.5%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 17.9116.7618.1510.7212.257.981.871.873.220.89
Operating Profit Margin (%) 26.1725.0120.7718.8517.2415.659.5710.118.458.85
Net Profit Margin (%) 13.1211.1311.547.288.176.611.911.852.960.8
Debt to Equity 0.330.320.280.140.120.10.0500.10.11
Working Capital Days 157139137146146201278273253246
Cash Conversion Cycle 5672819295131179172161165
Entity Percentage Holding
Promoters 54.37%
Non-Institutions 45.63%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Natural Capsules Ltd's performance infers:

Natural Capsules Ltd earnings have declined by -40.4%, whereas share price has appreciated 6% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Natural Capsules Ltd share prices over the last 10 years. Here is what we found out:

Natural Capsules Ltd share price has appreciated 12.5% annually over the past ten years.

Natural Capsules is a public limited company established in the year 1993.The company is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.   

The company meets the statutory requirements as laid down by the authorities in respect to cGMP and cGLP practices. Since its inception, Natural Capsules has ensured to provide turnkey solutions to all its customers.

Natural Capsules is a public limited company established in the year 1993.The company is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.   

The company meets the statutory requirements as laid down by the authorities in respect to cGMP and cGLP practices. Since its inception, Natural Capsules has ensured to provide turnkey solutions to all its customers. NCL has evolved and strengthened its endeavors by constantly innovating through its excellent products. With a mission to enable ‘Technology Assisted Business Transformation’, NCL ensure to deliver the best products with a technological edge.       

The main objective of the company is to manufacture and market hard gelatin capsule shells and hard cellulose capsule shells (both printed and unprinted). These capsules are sold in the domestic market and also exported to several countries. The logical integration of NCL hard shell manufacturing to formulation was initiated in the year 1998.  

The company is also engaged in formulating the pharmaceutical dosage forms in capsule dosage form, both pharma and neutraceutical products. The company is fully committed to upgrade its facilities on a continuous basis to meet the requirements of national and international standards, cGMP and cGLP practices. Natural Capsule has been serving the pharmaceutical industry over a decade, comprising of two units – one at Bangalore and other at Pondicherry.  

The pharmaceutical and dietary supplement industries count on Natural Capsules to supply hard two-piece gelatin and cellulose capsules. With manufacturing sites at Bangalore and Pondicherry, they are serving customers on quick service no matter where they are located. For the past 12 years, with the greatest respect to the customers, Natural Capsules has dedicated itself to the production of the highest quality capsules.

Products and services offered by the company:

Products:

  • Hard Gelatin Capsule Shells
  • Hard Cellulose Capsule Shells
  • BSE / TSE Free Gelatin Capsule Shells
  • Shiny Gelatin Capsule Shells  
  • SLS Free Gelatin Capsule Shells
  • Halal Certified Gelatin Capsule Shells
  • Fortified Gelatin Capsule Shells
  • Sweet Gelatin Capsule Shells
  • Fast Release Gelatin Capsule Shells
  • Printed Gelatin / Cellulose Capsule Shells

Services:    

  • Contract research in synthetic chemistry
  • Dosage development
  • Dossier in CTD format
  • Manufacturing of APIs and finished dosage forms
  • Development of dossiers/ ANDAs for products of the customer’s choice
  • Contract research and analytical 

Achievements/ recognition:

  •  An ISO 9001:2000 cerified company

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback